A detailed history of Alpha Dna Investment Management LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Alpha Dna Investment Management LLC holds 24,950 shares of NVCR stock, worth $768,460. This represents 0.15% of its overall portfolio holdings.

Number of Shares
24,950
Previous 20,353 22.59%
Holding current value
$768,460
Previous $348,000 11.78%
% of portfolio
0.15%
Previous 0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.61 - $23.34 $71,759 - $107,293
4,597 Added 22.59%
24,950 $389,000
Q2 2024

Aug 14, 2024

BUY
$11.83 - $24.05 $240,775 - $489,489
20,353 New
20,353 $348,000
Q2 2021

Aug 10, 2021

SELL
$130.4 - $225.58 $3,651 - $6,316
-28 Closed
0 $0
Q1 2021

May 12, 2021

SELL
$124.11 - $190.17 $744 - $1,141
-6 Reduced 17.65%
28 $3,000
Q4 2020

Feb 16, 2021

BUY
$112.16 - $174.14 $3,813 - $5,920
34 New
34 $5,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.23B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Alpha Dna Investment Management LLC Portfolio

Follow Alpha Dna Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Dna Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Dna Investment Management LLC with notifications on news.